These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6342656)

  • 1. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes.
    Atkinson K; Biggs JC; Hayes J; Ralston M; Dodds AJ; Concannon AJ; Naidoo D
    Br J Haematol; 1983 May; 54(1):59-67. PubMed ID: 6342655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease.
    Bacigalupo A; Di Giorgio F; Frassoni F; Van Lint MT; Raffo MR; Gogioso L; Viale M; Marmont AM
    Acta Haematol; 1984; 72(3):155-62. PubMed ID: 6438979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM
    Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia.
    Hows JM; Palmer S; Gordon-Smith EC
    Transplantation; 1982 Apr; 33(4):382-6. PubMed ID: 7041363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.
    Atkinson K; Biggs JC; Britton K; Short R; Mrongovius R; Concannon A; Dodds A
    Br J Haematol; 1984 Feb; 56(2):223-31. PubMed ID: 6362711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patients.
    Verhagen C; de Pauw BE; de Witte T; Holdrinet RS; Janssen JT; Williams KJ
    Blut; 1986 Oct; 53(4):333-9. PubMed ID: 3530352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.
    Klintmalm GB; Klingensmith WC; Iwatsuki S; Schröter GP; Starzl TE
    Radiology; 1982 Jan; 142(1):199-202. PubMed ID: 7031760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppression with cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anaemia: preliminary studies.
    Hows J; Harris R; Palmer S; Gordon-Smith EC
    Br J Haematol; 1981 Jun; 48(2):227-36. PubMed ID: 7016166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis.
    Feutren G; Friend D; Timonen P; Barnes A; Laburte C
    Br J Dermatol; 1990 Jun; 122 Suppl 36():85-93. PubMed ID: 2369572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ
    Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of cyclosporin A in human serum.
    Smith JM; Hows JM; Gordon-Smith EC
    J Clin Pathol; 1983 Jan; 36(1):41-3. PubMed ID: 6822676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary cytologic abnormalities in bone marrow transplant recipients of cyclosporin.
    Stella F; Troccoli R; Stella C; Battistelli S; Biagioni S; Giardini C; Baronciani D; Manenti F
    Acta Cytol; 1987; 31(5):615-9. PubMed ID: 3314304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients.
    Dieterle A; Gratwohl A; Nizze H; Huser B; Mihatsch MJ; Thiel G; Tichelli A; Signer E; Nissen C; Speck B
    Transplantation; 1990 Jun; 49(6):1093-100. PubMed ID: 2193442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin-A deposits in renal allografts.
    von Willebrand E; Häyry P
    Lancet; 1983 Jul; 2(8343):189-92. PubMed ID: 6135029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A.
    Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ
    Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosage of Cyclosporin A in children with renal transplants.
    Hoyer PF; Offner G; Wonigeit K; Brodehl J; Pichlmayr R
    Clin Nephrol; 1984 Aug; 22(2):68-71. PubMed ID: 6383673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
    Duraj FF; Bäckman L; Dati F; Ringdén O
    Transpl Int; 1991 Sep; 4(3):146-50. PubMed ID: 1720317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.